|
Originally published In Press as doi:10.1074/jbc.R600038200 on February 28, 2007
J. Biol. Chem., Vol. 282, Issue 16, 11613-11617, April 20, 2007
Minireview
Prostaglandin E Receptors*
Yukihiko Sugimoto and
Shuh Narumiya 1
From the
Department of Physiological Chemistry, Graduate School of Pharmaceutical Sciences and the Department of Pharmacology, Faculty of Medicine, Kyoto University, Kyoto 606-8501, Japan
Prostaglandin (PG) E2 exerts its actions by acting on a group of G-protein-coupled receptors (GPCRs). There are four GPCRs responding to PGE2 designated subtypes EP1, EP2, EP3, and EP4 and multiple splicing isoforms of the subtype EP3. The EP subtypes exhibit differences in signal transduction, tissue localization, and regulation of expression. This molecular and biochemical heterogeneity of PGE receptors leads to PGE2 being the most versatile prostanoid. Studies on knock-out mice deficient in each EP subtype have defined PGE2 actions mediated by each subtype and identified the role each EP subtype plays in various physiological and pathophysiological responses. Here we review recent advances in PGE receptor research.
* This minireview will be reprinted in the 2007 Minireview Compendium, which will be available in January, 2008. Work in our laboratories was supported in part by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports Science and Technology of Japan and from the Ministry of Health and Labor of Japan.
1 To whom correspondence should be addressed. E-mail: snaru{at}mfour.med.kyoto-u.ac.jp.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
N. N. Osborne, G.-Y. Li, D. Ji, B. L. Andrade da Costa, R. J. Fawcett, K. D. Kang, and K. D. Rittenhouse
Expression of Prostaglandin PGE2 Receptors under Conditions of Aging and Stress and the Protective Effect of the EP2 Agonist Butaprost on Retinal Ischemia
Invest. Ophthalmol. Vis. Sci.,
July 1, 2009;
50(7):
3238 - 3248.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. J. Baek, M. F. McEntee, and A. M. Legendre
REVIEW PAPER: Cancer Chemopreventive Compounds and Canine Cancer
Vet. Pathol.,
July 1, 2009;
46(4):
576 - 588.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Gilles, V. Mariani, M. Bryce, M. J. Mueller, J. Ring, T. Jakob, S. Pastore, H. Behrendt, and C. Traidl-Hoffmann
Pollen-Derived E1-Phytoprostanes Signal via PPAR-{gamma} and NF-{kappa}B-Dependent Mechanisms
J. Immunol.,
June 1, 2009;
182(11):
6653 - 6658.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Togo, X. Liu, X. Wang, H. Sugiura, K. Kamio, S. Kawasaki, T. Kobayashi, R. F. Ertl, Y. Ahn, O. Holz, et al.
PDE4 inhibitors roflumilast and rolipram augment PGE2 inhibition of TGF-{beta}1-stimulated fibroblasts
Am J Physiol Lung Cell Mol Physiol,
June 1, 2009;
296(6):
L959 - L969.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Hoggatt, P. Singh, J. Sampath, and L. M. Pelus
Prostaglandin E2 enhances hematopoietic stem cell homing, survival, and proliferation
Blood,
May 28, 2009;
113(22):
5444 - 5455.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Q. van der Merwe, C. L. Ohland, C. L. Hirota, and W. K. MacNaughton
Prostaglandin E2 Derived from Cyclooxygenases 1 and 2 Mediates Intestinal Epithelial Ion Transport Stimulated by the Activation of Protease-Activated Receptor 2
J. Pharmacol. Exp. Ther.,
May 1, 2009;
329(2):
747 - 752.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Herath, S. T. Lilly, D. P. Fischer, E. J. Williams, H. Dobson, C. E. Bryant, and I. M. Sheldon
Bacterial Lipopolysaccharide Induces an Endocrine Switch from Prostaglandin F2{alpha} to Prostaglandin E2 in Bovine Endometrium
Endocrinology,
April 1, 2009;
150(4):
1912 - 1920.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Lanaro, C. F. Franco-Penteado, D. M. Albuqueque, S. T. O. Saad, N. Conran, and F. F. Costa
Altered levels of cytokines and inflammatory mediators in plasma and leukocytes of sickle cell anemia patients and effects of hydroxyurea therapy
J. Leukoc. Biol.,
February 1, 2009;
85(2):
235 - 242.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Zhang, S. Liu, J. Liu, T. Zhang, Q. Shen, Y. Yu, and X. Cao
Immune Complex/Ig Negatively Regulate TLR4-Triggered Inflammatory Response in Macrophages through Fc{gamma}RIIb-Dependent PGE2 Production
J. Immunol.,
January 1, 2009;
182(1):
554 - 562.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Chen, M. Divangahi, H. Gan, D. S.J. Shin, S. Hong, D. M. Lee, C. N. Serhan, S. M. Behar, and H. G. Remold
Lipid mediators in innate immunity against tuberculosis: opposing roles of PGE2 and LXA4 in the induction of macrophage death
J. Exp. Med.,
November 24, 2008;
205(12):
2791 - 2801.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. M. Sturm, P. Schratl, R. Schuligoi, V. Konya, G. J. Sturm, I. Th. Lippe, B. A. Peskar, and A. Heinemann
Prostaglandin E2 Inhibits Eosinophil Trafficking through E-Prostanoid 2 Receptors
J. Immunol.,
November 15, 2008;
181(10):
7273 - 7283.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. L. Bogan, M. J. Murphy, R. L. Stouffer, and J. D. Hennebold
Prostaglandin Synthesis, Metabolism, and Signaling Potential in the Rhesus Macaque Corpus Luteum throughout the Luteal Phase of the Menstrual Cycle
Endocrinology,
November 1, 2008;
149(11):
5861 - 5871.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Sakanaka, S. Tanaka, Y. Sugimoto, and A. Ichikawa
Essential role of EP3 subtype in prostaglandin E2-induced adhesion of mouse cultured and peritoneal mast cells to the Arg-Gly-Asp-enriched matrix
Am J Physiol Cell Physiol,
November 1, 2008;
295(5):
C1427 - C1433.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Wallace
Prostaglandins, NSAIDs, and Gastric Mucosal Protection: Why Doesn't the Stomach Digest Itself?
Physiol Rev,
October 1, 2008;
88(4):
1547 - 1565.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Attur, H. E. Al-Mussawir, J. Patel, A. Kitay, M. Dave, G. Palmer, M. H. Pillinger, and S. B. Abramson
Prostaglandin E2 Exerts Catabolic Effects in Osteoarthritis Cartilage: Evidence for Signaling via the EP4 Receptor
J. Immunol.,
October 1, 2008;
181(7):
5082 - 5088.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Tamba, R. Yodoi, E. Segi-Nishida, A. Ichikawa, S. Narumiya, and Y. Sugimoto
Timely interaction between prostaglandin and chemokine signaling is a prerequisite for successful fertilization
PNAS,
September 23, 2008;
105(38):
14539 - 14544.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Shiraishi, H. Yoshida, K. Saeki, Y. Miura, S. Watanabe, T. Ishizaki, M. Hashimoto, G. Takaesu, T. Kobayashi, and A. Yoshimura
Prostaglandin E2 is a major soluble factor produced by stromal cells for preventing inflammatory cytokine production from dendritic cells
Int. Immunol.,
September 1, 2008;
20(9):
1219 - 1229.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Pierucci-Alves and B. D. Schultz
Bradykinin-Stimulated Cyclooxygenase Activity Stimulates Vas Deferens Epithelial Anion Secretion In Vitro in Swine and Humans
Biol Reprod,
September 1, 2008;
79(3):
501 - 509.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Togo, O. Holz, X. Liu, H. Sugiura, K. Kamio, X. Wang, S. Kawasaki, Y. Ahn, K. Fredriksson, C. M. Skold, et al.
Lung Fibroblast Repair Functions in Patients with Chronic Obstructive Pulmonary Disease Are Altered by Multiple Mechanisms
Am. J. Respir. Crit. Care Med.,
August 1, 2008;
178(3):
248 - 260.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Rastogi, A. Rickard, N. Dorokhov, D. J. Klumpp, and J. McHowat
Loss of prostaglandin E2 release from immortalized urothelial cells obtained from interstitial cystitis patient bladders
Am J Physiol Renal Physiol,
May 1, 2008;
294(5):
F1129 - F1135.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Tsuchiya, T. Oka, K. Nakamura, A. Ichikawa, C. B. Saper, and Y. Sugimoto
Prostaglandin E2 Attenuates Preoptic Expression of GABAA Receptors via EP3 Receptors
J. Biol. Chem.,
April 18, 2008;
283(16):
11064 - 11071.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Minami, K. Shimizu, Y. Okamoto, E. Folco, M.-L. Ilasaca, M. W. Feinberg, M. Aikawa, and P. Libby
Prostaglandin E Receptor Type 4-associated Protein Interacts Directly with NF-{kappa}B1 and Attenuates Macrophage Activation
J. Biol. Chem.,
April 11, 2008;
283(15):
9692 - 9703.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A.M. Patwardhan, J. Vela, J. Farugia, K. Vela, and K.M. Hargreaves
Trigeminal Nociceptors Express Prostaglandin Receptors
Journal of Dental Research,
March 1, 2008;
87(3):
262 - 266.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Subbaramaiah, C. Hudis, S.-H. Chang, T. Hla, and A. J. Dannenberg
EP2 and EP4 Receptors Regulate Aromatase Expression in Human Adipocytes and Breast Cancer Cells: EVIDENCE OF A BRCA1 AND p300 EXCHANGE
J. Biol. Chem.,
February 8, 2008;
283(6):
3433 - 3444.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L.-K. Sun, T. Reding, M. Bain, M. Heikenwalder, D. Bimmler, and R. Graf
Prostaglandin E2 modulates TNF-{alpha}-induced MCP-1 synthesis in pancreatic acinar cells in a PKA-dependent manner
Am J Physiol Gastrointest Liver Physiol,
December 1, 2007;
293(6):
G1196 - G1204.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. G Kennedy, C. Gillio-Meina, and S. H. Phang
Prostaglandins and the initiation of blastocyst implantation and decidualization
Reproduction,
November 1, 2007;
134(5):
635 - 643.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Wada, C. J. DeLong, Y. H. Hong, C. J. Rieke, I. Song, R. S. Sidhu, C. Yuan, M. Warnock, A. H. Schmaier, C. Yokoyama, et al.
Enzymes and Receptors of Prostaglandin Pathways with Arachidonic Acid-derived Versus Eicosapentaenoic Acid-derived Substrates and Products
J. Biol. Chem.,
August 3, 2007;
282(31):
22254 - 22266.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|